ARCHIVES

Reviewers Note Major Flaws In Design Of Burzynski’s Trials

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Federal Standards Improve Mammogram Quality, GAO Finds

November 17, 1995

FDA Approves NDA for Sodium Fluoride F18

February 4, 2011

Greenwald Lists Items Missing Because Not Enough Money Available

November 25, 1988

Cooperative Groups Other Investigators To Get Interferon When Available; DCT Recompetitions Okayed

April 4, 1980

Stronger Measures Needed To Reduce Conflict of Interest, IOM Report Says

May 1, 2009

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014